Company Profile

Neuromics Antibodies (AKA: Neuromics Inc)
Profile last edited on: 5/23/07      CAGE:       UEI:

Business Identifier: New drugs development through genomics
Year Founded
1999
First Award
2001
Latest Award
2001
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5325 West 74th Street Suite 8
Edina, MN 55439
   (952) 374-6161
   pshuster@neuromics1.com
   www.neuromics.com
Location: Single
Congr. District: 03
County: Hennepin

Public Profile

Neuromics antibodies has its roots in Neuromics, Inc. - a neuroscience-based biotechnology company dedicated to discovering novel genes involved in diseases of the nervous system and developing breakthrough therapies based on these discoveries. Both to support internal research and provide solutions for researchers worldwide, Neuromics, Inc developed and licensed antibodies. Customers found these antibodies to be of high quality and reasonably priced. As result a large percentage of business came from repeat orders.Neuromics Antibodies is carrying on the tradition of providing effective antibodies at the lowest prices anywhere. We are also continuing and expanding our relationship with our proven antibodies licensees

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2001 1 NIH $97,485
Project Title: Targeted delivery of antisense for the treatment of pain

Key People / Management

  Samuel J Shuster -- President

Company News

There are no news available.